173 related articles for article (PubMed ID: 3875162)
1. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.
Campbell DA; Poulter LW; Janossy G; du Bois RM
Thorax; 1985 Jun; 40(6):405-11. PubMed ID: 3875162
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of alveolitis by studies of lung biopsies.
Haslam PL
Lung; 1990; 168 Suppl():984-92. PubMed ID: 2117219
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
[TBL] [Abstract][Full Text] [Related]
4. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
[TBL] [Abstract][Full Text] [Related]
5. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
6. The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis.
Wallace WA; Howie SE; Krajewski AS; Lamb D
J Pathol; 1996 Mar; 178(3):323-9. PubMed ID: 8778339
[TBL] [Abstract][Full Text] [Related]
7. The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis.
Noble B; Du Bois RM; Poulter LW
Clin Exp Immunol; 1989 Apr; 76(1):41-6. PubMed ID: 2736799
[TBL] [Abstract][Full Text] [Related]
8. Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.
Kallenberg CG; Schilizzi BM; Beaumont F; Poppema S; De Leij L; The TH
Clin Exp Immunol; 1987 Jan; 67(1):182-90. PubMed ID: 3621672
[TBL] [Abstract][Full Text] [Related]
9. Immunofluorescent staining of lung biopsy in fibrosing alveolitis.
Poon MC; Epstein SW; Sepp H
Can Med Assoc J; 1973 Mar; 108(6):734-5 passim. PubMed ID: 4570681
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary gamma interferon production in patients with fibrosing alveolitis.
Robinson BW; Rose AH
Thorax; 1990 Feb; 45(2):105-8. PubMed ID: 2107589
[TBL] [Abstract][Full Text] [Related]
11. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
[TBL] [Abstract][Full Text] [Related]
12. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.
Wallace WA; Schofield JA; Lamb D; Howie SE
Thorax; 1994 Nov; 49(11):1139-45. PubMed ID: 7831631
[TBL] [Abstract][Full Text] [Related]
13. Usual interstitial pneumonitis is a T-cell alveolitis.
Kradin RL; Divertie MB; Colvin RB; Ramirez J; Ryu J; Carpenter HA; Bhan AK
Clin Immunol Immunopathol; 1986 Aug; 40(2):224-35. PubMed ID: 3521973
[TBL] [Abstract][Full Text] [Related]
14. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.
Wells AU; Lorimer S; Majumdar S; Harrison NK; Corrin B; Black CM; Jeffery PK; du Bois RM
Eur Respir J; 1995 Feb; 8(2):266-71. PubMed ID: 7758562
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.
Campbell DA; Poulter LW; Du Bois RM
Thorax; 1986 Jun; 41(6):429-34. PubMed ID: 3787519
[TBL] [Abstract][Full Text] [Related]
16. Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis.
Kallenberg CG; Schilizzi BM; Beaumont F; De Leij L; Poppema S; The TH
J Clin Pathol; 1987 Jul; 40(7):725-33. PubMed ID: 3305583
[TBL] [Abstract][Full Text] [Related]
17. Structural features of interstitial lung disease in systemic sclerosis.
Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis.
Kirk JM; Heard BE; Kerr I; Turner-Warwick M; Laurent GJ
Coll Relat Res; 1984 May; 4(3):169-82. PubMed ID: 6205817
[TBL] [Abstract][Full Text] [Related]
19. B7-1, B7-2 and class II MHC molecules in idiopathic pulmonary fibrosis and bronchiolitis obliterans-organizing pneumonia.
Kaneko Y; Kuwano K; Kunitake R; Kawasaki M; Hagimoto N; Hara N
Eur Respir J; 2000 Jan; 15(1):49-55. PubMed ID: 10678620
[TBL] [Abstract][Full Text] [Related]
20. The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions.
Wieczorek R; Jakobiec FA; Sacks EH; Knowles DM
Ophthalmology; 1988 Jan; 95(1):100-9. PubMed ID: 3278257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
